365
Views
3
CrossRef citations to date
0
Altmetric
Research Articles

Microneedle-assisted transdermal delivery of amlodipine besylate loaded nanoparticles

ORCID Icon, , ORCID Icon &
Pages 322-332 | Received 22 Nov 2021, Accepted 08 Aug 2022, Published online: 19 Aug 2022

References

  • Alkilani AZ, McCrudden MT, Donnelly RF. Transdermal drug delivery: innovative pharmaceutical developments based on disruption of the barrier properties of the stratum corneum. Pharmaceutics. 2015;7(4):438–470.
  • Ahmed Saeed Al-Japairai K, Mahmood S, Hamed Almurisi S, et al. Current trends in polymer microneedle for transdermal drug delivery. Int J Pharm. 2020;587:119673.
  • Yang D, Chen M, Sun Y, et al. Microneedle-mediated transdermal drug delivery for treating diverse skin diseases. Acta Biomater. 2021;121:119–133.
  • Donnelly RF, McCrudden MT, Zaid Alkilani A, et al. Hydrogel-forming microneedles prepared from “super swelling” polymers combined with lyophilised wafers for transdermal drug delivery. PLoS One. 2014;9(10):e111547.
  • Majumder J, Taratula O, Minko T. Nanocarrier-based systems for targeted and site specific therapeutic delivery. Adv Drug Deliv Rev. 2019;144:57–77.
  • Nance E. Careers in nanomedicine and drug delivery. Adv Drug Deliv Rev. 2019;144:180–189.
  • Qiao Q, Liu X, Yang T, et al. Nanomedicine for acute respiratory distress syndrome: the latest application, targeting strategy, and rational design. Acta Pharm Sin B. 2021;11(10):3060–3091.
  • Li C, Sun T, Jiang C. Recent advances in nanomedicines for the treatment of ischemic stroke. Acta Pharm Sin B. 2021;11(7):1767–1788.
  • Alkilani AZ, Nasereddin J, Hamed R, et al. Beneath the skin: a review of current trends and future prospects of transdermal drug delivery systems. Pharmaceutics. 2022;14(6):1152.
  • Patra JK, Das G, Fraceto LF, et al. Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnol. 2018;16(1):71.
  • Abu-Huwaij R, Al-Assaf SF, Hamed R. Recent exploration of nanoemulsions for drugs and cosmeceuticals delivery. J Cosmet Dermatol. 2021
  • Ding C, Li Z. A review of drug release mechanisms from nanocarrier systems. Mater Sci Eng C Mater Biol Appl. 2017;76:1440–1453.
  • Zaid Alkilani A, Hamed R, Hussein G, et al. Nanoemulsion-based patch for the dermal delivery of ascorbic acid. J Dispersion Sci Technol. 2021;:1–11.
  • Hamed R, Seder BY, Bardaweel SK, et al. Lipid-based formulations of microemulsion-loaded oleogels for the oral delivery of carvedilol. J Dispersion Sci Technol. 2021;:1–11.
  • Fares H, DiNicolantonio JJ, O’Keefe JH, et al. Amlodipine in hypertension: a first-line agent with efficacy for improving blood pressure and patient outcomes. Open Heart. 2016;3(2):e000473.
  • van der Vossen AC, van der Velde I, Smeets OS, et al. Design and stability study of an oral solution of amlodipine besylate for pediatric patients. Eur J Pharm Sci. 2016;92:220–223.
  • Tallian KB, Nahata MC, Turman MA, et al. Efficacy of amlodipine in pediatric patients with hypertension. Pediatr Nephrol. 1999;13(4):304–310.
  • Batchelor HK, Marriott JF. Formulations for children: problems and solutions. Br J Clin Pharmacol. 2015;79(3):405–418.
  • World Health Organization. Report of the informal expert meeting on dosage forms of medicines for children. Geneva (Switzerland): WHO; 2008.
  • Al-Nemrawi NK, Alsharif SSM, Alzoubi KH, et al. Preparation and characterization of insulin chitosan-nanoparticles loaded in buccal films. Pharm Dev Technol. 2019;24(8):967–974.
  • Wang WT, Liu JG, Sun WH, et al. Widely tunable single bandpass microwave photonic filter based on brillouin-assisted optical carrier recovery. Opt Express. 2014;22(24):29304–29313.
  • Tas C, Ozkan Y, Okyar A, et al. In vitro and ex vivo permeation studies of etodolac from hydrophilic gels and effect of terpenes as enhancers. Drug Deliv. 2007;14(7):453–459.
  • Guideline IHT. Validation of analytical procedures: text and methodology. Q2 (R1). 2005;1(20):05.
  • Niaz T, Shabbir S, Manzoor S, et al. Antihypertensive nano-ceuticales based on chitosan biopolymer: physico-chemical evaluation and release kinetics. Carbohydr Polym. 2016;142:268–274.
  • Rabea EI, Badawy ME, Stevens CV, et al. Chitosan as antimicrobial agent: applications and mode of action. Biomacromolecules. 2003;4(6):1457–1465.
  • Pawlak A, Mucha M. Thermogravimetric and FTIR studies of chitosan blends. Thermochim Acta. 2003;396(1–2):153–166.
  • Ibrahim M, Osman O, Mahmoud AA. Spectroscopic analyses of cellulose and chitosan: FTIR and modeling approach. J Comp Theo Nano. 2011;8(1):117–123.
  • Ramirez-Tagle R, Salgado-Moran G, Mendez-Luna D, et al. Synthesis, chemical identification, drug release and docking studies of the amlodipine–chitosan nanobiopolymer composite. J Chil Chem Soc. 2021;66(1):5063–5066.
  • Bukhary H, Williams GR, Orlu M. Electrospun fixed dose formulations of amlodipine besylate and valsartan. Int J Pharm. 2018;549(1–2):446–455.
  • Huang YC, Li RY, Chen JY, et al. Biphasic release of gentamicin from chitosan/fucoidan nanoparticles for pulmonary delivery. Carbohydr Polym. 2016;138:114–122.
  • Shi L, Tang C, Yin C. Glycyrrhizin-modified O-carboxymethyl chitosan nanoparticles as drug vehicles targeting hepatocellular carcinoma. Biomaterials. 2012;33(30):7594–7604.
  • Tekko IA, Chen G, Dominguez-Robles J, et al. Development and characterisation of novel poly (vinyl alcohol)/poly (vinyl pyrrolidone)-based hydrogel-forming microneedle arrays for enhanced and sustained transdermal delivery of methotrexate. Int J Pharm. 2020;586:119580.
  • Lim LY, Wan LSC. The effect of plasticizers on the properties of polyvinyl alcohol films. Drug Dev Ind Pharm. 1994;20(6):1007–1020.
  • Kristmundsdottir T, Aradottir HA, Ingolfsdottir K, et al. Solubilization of the lichen metabolite (+)-usnic acid for testing in tissue culture. J Pharm Pharmacol. 2002;54(11):1447–1452.
  • McDaid DM, Deasy PB. Formulation development of a transdermal drug delivery system for amlodipine base. Int J Pharm. 1996;133(1–2):71–83.
  • Zhang P, Zhang Y, Liu C-G. Polymeric nanoparticles based on carboxymethyl chitosan in combination with painless microneedle therapy systems for enhancing transdermal insulin delivery. RSC Adv. 2020;10(41):24319–24329.
  • Permana AD, Mir M, Utomo E, et al. Bacterially sensitive nanoparticle-based dissolving microneedles of doxycycline for enhanced treatment of bacterial biofilm skin infection: a proof of concept study. Int J Pharm X. 2020;2:100047.
  • Khalil SK, El-Feky GS, El-Banna ST, et al. Preparation and evaluation of warfarin-beta-cyclodextrin loaded chitosan nanoparticles for transdermal delivery. Carbohydr Polym. 2012;90(3):1244–1253.
  • Nair RS, Morris A, Billa N, et al. An evaluation of curcumin-encapsulated chitosan nanoparticles for transdermal delivery. AAPS PharmSciTech. 2019;20(2):69.
  • Hafner A, Lovric J, Pepic I, et al. Lecithin/chitosan nanoparticles for transdermal delivery of melatonin. J Microencapsul. 2011;28(8):807–815.
  • Desai P, Patlolla RR, Singh M. Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug delivery. Mol Membr Biol. 2010;27(7):247–259.
  • Ramadan E, Borg T, Abdelghani GM, et al. Transdermal microneedle-mediated delivery of polymeric lamivudine-loaded nanoparticles. J Pharm Technol Drug Res. 2016;5(1):1.
  • Gomaa YA, El-Khordagui LK, Garland MJ, et al. Effect of microneedle treatment on the skin permeation of a nanoencapsulated dye. J Pharm Pharmacol. 2012;64(11):1592–1602.
  • Zhang W, Gao J, Zhu Q, et al. Penetration and distribution of PLGA nanoparticles in the human skin treated with microneedles. Int J Pharm. 2010;402(1–2):205–212.
  • Kaur M, Ita KB, Popova IE, et al. Microneedle-assisted delivery of verapamil hydrochloride and amlodipine besylate. Eur J Pharm Biopharm. 2014;86(2):284–291.
  • Donnelly RF, Singh TR, Garland MJ, et al. Hydrogel-Forming microneedle arrays for enhanced transdermal drug delivery. Adv Funct Mater. 2012;22(23):4879–4890.
  • Tahara K, Yamamoto K, Nishihata T. Overall mechanism behind matrix sustained release (SR) tablets prepared with hydroxypropyl methylcellulose 2910. J Contr Rel. 1995;35(1):59–66.
  • Sung KC, Nixon P, Skoug J, et al. Effect of formulation variables on drug and polymer release from HPMC-based matrix tablets. Int J Pharm. 1996;142(1):53–60.
  • Gouda R, Baishya H, Qing Z. Application of mathematical models in drug release kinetics of carbidopa and levodopa ER tablets. J Dev Drugs. 2017;6(02):1–8.
  • Naskar S, Koutsu K, Sharma S. Chitosan-based nanoparticles as drug delivery systems: a review on two decades of research. J Drug Target. 2019;27(4):379–393.
  • Timotius D, Kusumastuti Y, Imani NAC, et al. Kinetics of drug release profile from maleic anhydride-grafted-chitosan film. Mater Res Express. 2020;7(4):046403.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.